Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $57.36 ($491K) on 2015-06-01, disclosed to the SEC on 2015-06-03.
Scheduled sale ($491k) by VP, Product Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.31 | 4,251 | $231K | 47.0% |
| 2 | $54.76 | 4,559 | $250K | 50.8% |
| 3 | $57.36 | 190 | $11K | 2.2% |
| Total | $54.60 avg | 9,000 | $491K | 100% |
| Filing → |
| KITE | SELL | 2015-12-03 | $687K | — | Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |